X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.fiercepharma.com/pharma/fda-rejects-defenders-motion-sickness-nasal-gel-candidate#:~:text=A%20nasal%20gel%20version%20of%20the%20motion%20sickness%20drug%20scopolamine,and%20vomiting%20induced%20by%20motion.
https://www.globenewswire.com/news-release/2024/01/30/2820312/0/en/Defender-Pharmaceuticals-Receives-Complete-Response-Letter-from-the-U-S-Food-and-Drug-Administration-for-its-Intranasal-Scopolamine-DPI-386-New-Drug-Application-for-the-Prevention-.html
https://www.globenewswire.com//news-release/2023/09/26/2749419/0/en/FDA-Accepts-Defender-Pharmaceuticals-New-Drug-Application-for-Intranasal-Scopolamine-Gel.html
https://www.globenewswire.com/news-release/2023/07/26/2711490/0/en/Defender-Pharmaceuticals-Announces-Submission-of-New-Drug-Application-to-FDA-with-Intranasal-Scopolamine-for-Prevention-of-Nausea-and-Vomiting-Induced-by-Motion-in-Adults.html
https://www.globenewswire.com/news-release/2023/06/05/2682084/0/en/Defender-Pharmaceuticals-Reports-Positive-Results-from-Pivotal-Phase-III-Clinical-Trial-of-Intranasal-Scopolamine-for-the-Prevention-of-Nausea-and-Vomiting-Induced-by-Motion.html
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208769
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212342
https://www.transopharm.com/blog/scopolamine-base-hydrobromide-methylbromide-niche-phyto-apis-from-transo-pharm
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203753
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-23-2018-1527054176.pdf
http://www.prnewswire.com/news-releases/perrigo-announces-the-launch-of-the-ab-rated-generic-version-of-transderm-scop-15-mg-300496534.html
http://www.in-pharmatechnologist.com/Regulatory-Safety/WHO-hopeful-Assad-Government-will-allow-surgical-supplies-into-Moadamiyeh
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+medicamento+por+nao+passar+no+ensaio+de+aspecto
Market Place
Share 
